Skip to main content
Log in

The secretin test in the diagnosis of pancreatic diseases with a report of one hundred thirty tests

  • Published:
The American Journal of Digestive Diseases

Summary and Conclusions

Secretin, given intravenously in dosage of 0.75 mg./Kg, of body weight, causes a marked response in the flow of pancreatic juice. The use of a double lumen gastro-duodenal tube provides a clear uncontaminated juice rich in bicarbonate and enzymes.

The external secretion of the pancreas may be regarded as governed by a neuro-hormonal factor. The volume and bicarbonate secretion is directly proportional to the amount of Secretin injected while the production of enzymes is dependent in addition upon a neurogenic or vagal tone. When Secretin alone is injected, pancreatic juice of low enzyme concentration is elaborated. When insulin or other vagal stimuli are used in conjunction with Secretin the enzyme concentration is increased two to three fold.

In severe lesions of the pancreas all functions are simultaneously involved and become markedly diminished. In milder forms the enzyme production is the first to suffer. The volume and bicarbonate are more stable and are less easily disturbed.

The enzymes may become dissociated so that one may become more affected than another.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Colp, R. and Doubilet, H.: Clinical Significance of Pancreatic Reflux.Ann. Surg., 108:243, 1938. AlsoSurgery, 4:837, 1938.

    Article  PubMed  CAS  Google Scholar 

  2. Leven, N. L.: Reflux Into the Major Pancreatic Duct During Cholangiography.Proc. Soc. of Exp. Med. and Biol. 38:808. 1938.

    Google Scholar 

  3. Andersen, Dorothy H.: Cystic Fibrosis of the Pancreas and Its Relation to Celiac Disease.Am. J. Dis. Child., 56:355–399 Aug., 1938.

    Google Scholar 

  4. Hammarsten, E., Agren, G., Hammarsten, H. and Wilander, O.: Versuche zur Reinigund von Sekretin.Biochem. Ztschr., 264 : 275–284. 1933.

    Google Scholar 

  5. Agren, G. and Hammarsten, E.: Behavior of Crystallized Seeretin When Digested with Proteolytic Enzymes.J. Physiol., 90:330, 1937.

    PubMed  CAS  Google Scholar 

  6. Diamond, Joseph S., Siegel, S. A., Gall, M. B. and Karlen, S.: The Use of Secretin as a Clinical Test of Pancreatic Function.Am. J. Dig. Dis., 6:366–372, 1939.

    CAS  Google Scholar 

  7. Diamond, Joseph S., Siegel, S. A. and Myerson, S.: The Biliary Pigment Curve During the Secretin Test.Am. J. Dip. Dis., 7:133–138. 1940.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was aided by the “Dr. Max Rosenthal Research Fund.”

Read before the Annual Meeting of the American Gastro-Enterological Association, Atlantic City, N. J., June 10 and 11, 1940.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Diamond, J.S., Siegel, S.A. & Kantor, J.L. The secretin test in the diagnosis of pancreatic diseases with a report of one hundred thirty tests. Jour. D. D. 7, 435–442 (1940). https://doi.org/10.1007/BF02997392

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02997392

Keywords

Navigation